Boston Sci ($BSX) to get tax credit

After denying the company a state tax break because it did not hit job creation targets, the state has negotiated a deal with Boston Scientific ($BSX) that will grant it tax credits for eight years in exchange for expanding its operations on the North Quincy waterfront. News

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.